Hostname: page-component-6766d58669-kn6lq Total loading time: 0 Render date: 2026-05-19T00:35:26.121Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of herpes zoster virus reactivation in patients diagnosed with Bell's palsy

Published online by Cambridge University Press:  12 January 2022

R Freire de Castro Open the ORCID record for R Freire de Castro [Opens in a new window] ,
D Crema ,
F C Neiva ,
R A S R Pinto  and
F A Suzuki
R Freire de Castro*
Affiliation:
Department of Otorhinolaryngology and Cervico-Facial Surgery, São Paulo, Brazil
D Crema
Affiliation:
Department of Clinical Analysis – Immunology Laboratory, São Paulo, Brazil
F C Neiva
Affiliation:
Department of Otorhinolaryngology and Cervico-Facial Surgery, São Paulo, Brazil
R A S R Pinto
Affiliation:
Department of Clinical Neurology, Instituto de Assistência Médica ao Servidor Público Estadual, São Paulo, Brazil
F A Suzuki
Affiliation:
Department of Otorhinolaryngology and Cervico-Facial Surgery, São Paulo, Brazil
*
Author for correspondence: Dr Rafael Freire de Castro, Departamento de Otorrinolaringologia e Cirurgia Cérvico-Facial, Instituto de Assistência Médica ao Servidor Público Estadual, Avenida Ibirapuera 981, Vila Clementino, São Paulo, SP – 04029-000, Brasil E-mail: rafaelfreire.uftm@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Herpes zoster virus can cause inflammatory neuropathy of the facial nerve. However, studies evaluating the prevalence of this agent in peripheral facial palsy are heterogeneous regarding sample group selection, laboratory analysis method and variables studied. In addition, there are a lack of epidemiological data in the Brazilian population on this serological phenomenon in peripheral facial palsy. This study estimated herpes zoster reactivation prevalence in serological samples through chemiluminescence immunoassay for quantitative determination of specific antibodies directed against the virus.

Methods

This cross-sectional study sought to determine the prevalence of viral reactivation by herpes zoster in subjects with idiopathic peripheral facial palsy through analysis of serological samples over a year.

Results

Forty-seven patients (32 females and 15 males) participated. Severe paralysis was more common in older patients (p = 0.017). Facial pain (p = 0.02) and vertigo (p = 0.001) were related to a worse evolution of facial palsy. The rate of serological reactivation of the virus was 12.76 per cent.

Conclusion

The rate of serological reactivation of herpes virus in idiopathic peripheral facial palsy in our population is similar to foreign literature data, suggesting similar aetiological mechanisms in the genesis of this morbidity.

Keywords

Varicella Zoster Virus InfectionZoster Sine HerpeteChickenpoxBell PalsyHerpes Zoster

Information

Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 136 , Issue 10 , October 2022 , pp. 975 - 978
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Dr R Freire de Castro takes responsibility for the integrity of the content of the paper

References

Allen, D, Dunn, L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004;(3):CD001869CrossRefGoogle Scholar
Sullivan, FM, Swan, I, Donnan, PT, Morrison, JM, Smith, BH, McKinstry, B et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007;357:1598–607CrossRefGoogle ScholarPubMed
Greco, A, Gallo, A, Fusconi, M, Marinelli, C, Macri, GF, de Vincentiis, M. Bell's palsy and autoimmunity. Autoimmun Rev 2012;12:323–8CrossRefGoogle ScholarPubMed
McCormick, DP. Herpes simplex virus as a cause of Bell's palsy. Lancet 1972;1:937–9CrossRefGoogle ScholarPubMed
Lee, HY, Kim, MG, Park, DC, Park, MS, Byun, JY, Yeo, SG. Zoster sine herpete causing facial palsy. Am J Otolaryngol 2012;33:565–71CrossRefGoogle ScholarPubMed
Kawaguchi, K, Inamura, H, Abe, Y, Koshu, H, Takashita, E, Muraki, Y et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 2007;117:147–56CrossRefGoogle ScholarPubMed
Zandian, A, Osiro, S, Hudson, R, Ali, IM, Matusz, P, Tubbs, SR et al. The neurologist's dilemma: a comprehensive clinical review of Bell's palsy, with emphasis on current management trends. Med Sci Monit 2014;20:83–90Google ScholarPubMed
Zhao, Y, Feng, G, Gao, Z. Advances in diagnosis and non-surgical treatment of Bell's palsy. J Otol 2015;10:7–12CrossRefGoogle ScholarPubMed
Furuta, Y, Ohtani, F, Kawabata, H, Fukuda, S, Bergström, T. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis 2000;30:529–33CrossRefGoogle ScholarPubMed
Santos, MAO, Caiaffa Filho, HH, Vianna, MF, Almeida, AGP, Lazarini, PR. Varicella zoster virus in Bell's palsy: a prospective study. Braz J Otorhinolaryngol 2010;76:370–3CrossRefGoogle ScholarPubMed
Adour, KK, Bell, DN, Hilsinger, RL. Herpes simplex virus in idiopathic facial paralysis (Bell palsy). JAMA 1975;233:527–30CrossRefGoogle Scholar
Ogita, S, Terada, K, Niizuma, T, Kosaka, Y, Kataoka, N. Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella-zoster virus association. Pediatr Int 2006;48:245–9CrossRefGoogle ScholarPubMed
Turriziani, O, Falasca, F, Maida, P, Gaeta, A, De Vito, C, Mancini, P et al. Early collection of saliva specimens from Bell's palsy patients: quantitative analysis of HHV-6, HSV-1, and VZV. J Med Virol 2014;86:1752–8CrossRefGoogle ScholarPubMed
House, JW, Brackmann, DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146–7CrossRefGoogle ScholarPubMed
Sauerbrei, A, Eichhorn, U, Schacke, M, Wutzler, P. Laboratory diagnosis of herpes zoster. J Clin Virol 1999;14:31–6Google ScholarPubMed
Diasorin. LIAISON® VZV IgG and IgM: The fully automated solution for antibody detection. In: https://www.diasorin.com/en/immunodiagnostic-solutions/clinical-areas [15 January 2020]Google Scholar
Furuta, Y, Ohtani, F, Aizawa, H, Fukuda, S, Kawabata, H, Bergström, T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005;24:97–101CrossRefGoogle ScholarPubMed
Junior, NA, Junior, JJJ, Gignon, VF, Kitice, AT, Prado, LSA, Santos, VGW et al. Facial nerve palsy: incidence of different ethiologies in a tertiary ambulatory. Int Arch Otorhinolaryngol 2009;13:167–71Google Scholar
Baugh, RF, Basura, GJ, Ishii, LE, Schwartz, SR, Drumheller, CM, Burkholder, R et al. Clinical practice guideline: Bell's palsy executive summary. Otolaryngol Head Neck Surg 2013;149:656–63CrossRefGoogle ScholarPubMed
Monini, S, Lazzarino, A, Iacolucci, C, Buffoni, A, Barbara, M. Epidemiology of Bell's palsy in an Italian health district: incidence and case-control study. Acta Otorhinolaryngol Ital 2010;30:198Google Scholar
Hato, N, Sawai, N, Teraoka, M, Wakisaka, H, Takahashi, H, Hinohira, Y et al. Valacyclovir for the treatment of Bell's palsy. Expert Opin Pharmacother 2008;9:2531–6CrossRefGoogle ScholarPubMed